Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Crescent Innovations Inc. Reports That Inquiries Surrounding Sale of Its Bone Repair Technology Are Increasing
-
Vera Therapeutics to Participate at September Investor Conferences
-
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
-
SSCP Lager Bidco AB (publ) – Interim report for second quarter 2024
-
Fenbo Holdings Limited Taps into AI Innovations through Investment in a U.S. AI Focused Fund
-
Pasinex Announces Filing of 2024 Second Quarter Financial Results
-
Form 8.3 - Keywords Studios Plc
-
Alliance Trust PLC - Net Asset Value
-
Form 8.3 - Mattioli Woods plc - Octopus Investments
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
Timus Networks Provides Oracle Cloud Customers with Enhanced Network Protection and Secure Remote Access
-
OKX Wallet Now Integrated with Kryptomon
-
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
-
KANZHUN LIMITED Announces Adoption of New Share Repurchase Program
-
Onex Partners to Acquire Farsound
-
GURU Organic Energy to Report Third Quarter 2024 Results
-
BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
-
Notable Labs to Present Data on September 4th at SOHO 2024
-
Electra Engages Altitude Capital Consultants
-
Ollie’s Bargain Outlet Holdings, Inc. Reports Second Quarter Fiscal 2024 Financial Results
-
BridgeBio to Present Additional Analyses from the Phase 3 ATTRibute-CM Trial of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the ESC Congress 2024 and the HFSA Annual
-
MasterCraft Boat Holdings, Inc. Reports Fiscal 2024 Results
-
Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease
-
Zevra Therapeutics to Participate at Upcoming Investor Conferences
-
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
-
Chart Industries and Element Resources Partner on Hydrogen Eco-System Deployment
-
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
-
Inaugural Pre-JPM Partnering Week to Wrap Up 2024, Prepare for 2025
-
Nu:ionic Technologies and RW Energy Announce Strategic Alliance for Distributed Scale Hydrogen Production and CO2 Capture Projects
-
Researchers call for individualized gene therapies to be more widely accessible
-
Tims China Announces Second Quarter 2024 Financial Results
-
Innofactor Plc: Managers’ Transactions – Jørn Ellefsen
-
OKX Announces Support for MATIC Token Migration to POL
-
Nikkiso Clean Energy & Industrial Gases Group Announces It Will Double Manufacturing Capacity in Europe
-
Nikkiso Clean Energy & Industrial Gases Group Announces It Will Double Manufacturing Capacity in Europe
-
Lifecore Biomedical Announces Chief Financial Officer Transition
-
Arvinas to Participate in Upcoming Investor Conferences
-
Mikra Ships FOCUS Ahead of Schedule and Prepares for Marketing Push
-
17 Education & Technology Group Inc. to Report Second Quarter 2024 Unaudited Financial Results on September 4, 2024
-
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
-
POET Streamlines its Global Engineering Organization in Response to AI Market Demand
-
Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Re
-
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
-
BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
-
17 Education & Technology Group Inc. to Report Second Quarter 2024 Unaudited Financial Results on September 4, 2024
-
Adagene to Participate in Investor Conferences in September
-
G-III Apparel Group Announces Date for Second Quarter 2025 Results
-
Rivalry Reports Second Quarter 2024 Results; Rivalry Token Drives $1.7 Million in Additional Revenue, Accelerating Crypto Expansion Efforts in the Third Quarter
